Europe Medical Aesthetic Devices Market Introduction and Overview
According to SPER Market Research, the Europe Medical Aesthetic Devices Market is estimated to reach USD XX Billion by 2033 with a CAGR of 11.67%.
The report includes an in-depth analysis of the Europe Medical Aesthetic Devices Market, including market size and trends, product mix, applications, and supplier analysis. Medical aesthetic devices are specialised equipment and instruments used in cosmetic operations to enhance people's aesthetic look. These gadgets are intended to be less invasive and provide non-surgical alternatives to traditional cosmetic surgery. Medical aesthetic devices use technologies including laser, radiofrequency, ultrasound, and light therapy to target particular parts of the body and address a variety of aesthetic disorders. These devices are used for a variety of procedures, including skin rejuvenation, hair removal, body sculpting, and facial augmentation.
- October 2022: Evolus, Inc. entered the British market in, beginning commercial operations and shipping Nuceiva (botulinum toxin type A). This move sought to increase the company's footprint in the European market while also giving patients with a new alternative for aesthetic treatments.
- October 2022: GC Aesthetics got CE mark clearance for their new micro-textured anatomical breast implant, the LUNA xt, under the new European Medical Device Regulation (MDR). This certification allows the company to market and distribute the implant within the European Union, giving women a new alternative for breast augmentation surgery. The novel implant has a unique form and texture that seeks to improve patient outcomes while lowering the risk of problems.
Market Opportunities and Challenges
The Europe medical aesthetic devices market presents a range of opportunities amid certain challenges. Opportunities include the increasing demand for minimally invasive procedures, driven by a growing consumer preference for non-surgical aesthetic treatments. Advancements in technology, such as laser therapy and energy-based devices, offer innovative solutions for various aesthetic concerns, contributing to market growth. Additionally, the rising adoption of aesthetic procedures among the aging population and younger demographics seeking cosmetic enhancements fuels market expansion.
However, challenges persist, including stringent regulatory requirements and compliance standards that may hinder market entry for manufacturers. Economic uncertainties and healthcare budget constraints in some European countries could also impede market growth. Furthermore, competition among market players and the need for continuous innovation pose challenges for sustaining market leadership and differentiation. Overall, navigating these opportunities and challenges requires strategic investments in research and development, regulatory compliance, and market expansion initiatives.
Market Competitive Landscape
The European market for medical aesthetic devices is moderately fragmented, with both small and major manufacturers present. To preserve their market position, these corporations use a variety of critical techniques, including partnerships, product approvals, and collaborations. The major key players in the Europe Medical Aesthetic Devices Market are: Abbvie Inc (Allergan Inc.), Aerolase Corporation, Bausch Health Companies Inc. (Solta Medical Inc.), Cynosure, Cutera Inc., Galderma SA, Human Med AG, Johnson & Johnson (Mentor Worldwide), Lumenis Inc., Merz Pharma GmbH & Co. KGaA, Sciton Inc., Sisram Medical (Alma Lasers), Syneron Medical Ltd, Others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Type, By Application, By End User
|
| Regions covered | Belgium, France, Germany, Italy, Netherlands, Russia, Spain, Switzerland, The U.K., Turkey, Rest of Europe
|
| Companies Covered | Abbvie Inc (Allergan Inc.), Aerolase Corporation, Bausch Health Companies Inc. (Solta Medical Inc.), Cynosure, Cutera Inc., Galderma SA, Human Med AG, Johnson & Johnson (Mentor Worldwide), Lumenis Inc., Merz Pharma GmbH & Co. KGaA, Sciton Inc., Sisram Medical (Alma Lasers), Syneron Medical Ltd, Others.
|
COVID-19 Impact on Europe Medical Aesthetic Devices Market
The COVID-19 epidemic had a huge impact on Europe's medical aesthetic device business. The temporary closure of aesthetic clinics and the halting of non-essential services during lockdowns led to a market drop. However, as restrictions were lifted and clinics reopened, the demand for aesthetic procedures began to rebound. The pandemic underlined the need of non-surgical therapies, as patients sought minimally invasive procedures with shorter recovery times. Virtual consultations and telemedicine solutions gained popularity, allowing for distant examinations and consultations. To protect the well-being of patients and personnel, the market has seen an increase in attention on safety measures and infection control methods.
Key Target Audience:
- Clinics and Medical Spas
- Hospitals and Surgical Centers
- Dermatologists and Plastic Surgeons
- Aesthetic Practitioners
- Medical Device Manufacturers
- Distributors and Suppliers
- Healthcare Professionals
- Others
Our in-depth analysis of the Europe Medical Aesthetic Devices Market includes the following segments:
|
By Type: |
Energy-Based Aesthetic Devices
Non-Energy-Based Aesthetic Devices
|
|
By Application: |
Body Contouring and Cellulite Reduction
Breast Augmentation
Hair Removal
Skin Resurfacing and Tightening
Other Applications
|
|
By End User: |
Clinics
Hospitals
Other End-Users
|
Key Topics Covered in the Report:
- Europe Medical Aesthetic Devices Market Size (FY’2024-FY’2033)
- Overview of Europe Medical Aesthetic Devices Market
- Segmentation of Europe Medical Aesthetic Devices Market By Type (Energy-Based Aesthetic Devices, Non-Energy-Based Aesthetic Devices)
- Segmentation of Europe Medical Aesthetic Devices Market By Application (Body Contouring and Cellulite Reduction, Breast Augmentation, Hair Removal, Skin Resurfacing and Tightening, Other Applications)
- Segmentation of Europe Medical Aesthetic Devices Market By End User (Clinics, Hospitals, Other End-Users Clinics, Hospitals, Other End-Users)
- Statistical Snap of Europe Medical Aesthetic Devices Market
- Expansion Analysis of Europe Medical Aesthetic Devices Market
- Problems and Obstacles in Europe Medical Aesthetic Devices Market
- Competitive Landscape in the Europe Medical Aesthetic Devices Market
- Impact of COVID-19 and Demonetization on Europe Medical Aesthetic Devices Market
- Details on Current Investment in Europe Medical Aesthetic Devices Market
- Competitive Analysis of Europe Medical Aesthetic Devices Market
- Prominent Players in the Europe Medical Aesthetic Devices Market
- SWOT Analysis of Europe Medical Aesthetic Devices Market
- Europe Medical Aesthetic Devices Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Europe Medical Aesthetic Devices Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Europe Medical Aesthetic Devices Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe Medical Aesthetic Devices Market
7. Europe Medical Aesthetic Devices Market, By Type (USD Million) 2020-2033
7.1. Europe Medical Aesthetic Devices Market Size, Share and Forecast, By Type, 2020-2026
7.2. Europe Medical Aesthetic Devices Market Size, Share and Forecast, By Type, 2027-2033
7.3. Energy-Based Aesthetic Devices
7.3.1. Laser-based Aesthetic Devices
7.3.2. Light-based Aesthetic Devices
7.3.3. Radiofrequency (RF) Based Aesthetic Devices
7.3.4. Ultrasound Aesthetic Devices
7.4. Non-Energy-Based Aesthetic Devices
7.4.1. Botulinum Toxin
7.4.2. Chemical Peels
7.4.3. Dermal Fillers and Aesthetic Threads
7.4.4. Implants
7.4.5. Microdermabrasion
7.4.6. Other Aesthetic Devices
8. Europe Medical Aesthetic Devices Market, By Application (USD Million) 2020-2033
8.1. Europe Medical Aesthetic Devices Market Size, Share and Forecast, By Application, 2020-2026
8.2. Europe Medical Aesthetic Devices Market Size, Share and Forecast, By Application, 2027-2033
8.3. Body Contouring and Cellulite Reduction
8.4. Breast Augmentation
8.5. Hair Removal
8.6. Skin Resurfacing and Tightening
8.7. Other Applications
9. Europe Medical Aesthetic Devices Market, By End User (USD Million) 2020-2033
9.1. Europe Medical Aesthetic Devices Market Size, Share and Forecast, By End User, 2020-2026
9.2. Europe Medical Aesthetic Devices Market Size, Share and Forecast, By End User, 2027-2033
9.3. Clinics
9.4. Hospitals
9.5. Other End-Users
10. Europe Medical Aesthetic Devices Market Forecast, 2020-2033 (USD Million)
10.1. Europe Medical Aesthetic Devices Market Size and Market Share
11. Europe Medical Aesthetic Devices Market, By Region, 2020-2033 (USD Million)
11.1. Europe Medical Aesthetic Devices Market Size and Market Share By Region (2020-2026)
11.2. Europe Medical Aesthetic Devices Market Size and Market Share By Region (2027-2033)
11.3. Belgium
11.4. France
11.5. Germany
11.6. Italy
11.7. Netherlands
11.8. Russia
11.9. Spain
11.10. Switzerland
11.11. Turkey
11.12. U.K.
11.13. Rest of Europe in Europe
12. Company Profile
12.1. Abbvie Inc (Allergan Inc)
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Aerolase Corporation
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Bausch Health Companies Inc. (Solta Medical Inc.)
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Cynosure
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Cutera Inc
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Galderma SA
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Human Med AG
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Johnson & Johnson (Mentor Worldwide)
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Lumenis Inc
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Merz Pharma GmbH & Co. KGaA
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Sciton Inc
12.11.1. Company details
12.11.2. Financial outlook
12.11.3. Product summary
12.11.4. Recent developments
12.12. Sisram Medical (Alma Lasers)
12.12.1. Company details
12.12.2. Financial outlook
12.12.3. Product summary
12.12.4. Recent developments
12.13. Syneron Medical Ltd
12.13.1. Company details
12.13.2. Financial outlook
12.13.3. Product summary
12.13.4. Recent developments
12.14. Others
13. List of Abbreviations
14. Reference Links
15. Conclusion
16. Research Scope